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Aim: Controversies exist on the optimal diagnostic workup for neonates with esophageal
atresia (EA) with/without tracheoesophageal fistula (TEF). Aim of this study was to
describe the current diagnostic policies in EA/TEF patients enrolled in an International
multicenter registry.
Methods: All patients consecutively registered from July 2014 to December 2017
in the EUPSA Esophageal Atresia Registry (EUPSA-EAR) were included in the study.
Data related to diagnostic investigations among Centers forming the EUPSA-EAR
were analyzed.
Main Results: During the study period, 374 consecutive patients were recorded by 23
Centers. The majority of patients underwent chest X-rays, echocardiography, abdominal
ultrasound, and abdominal X-rays. Preoperative bronchoscopy and esophageal gap
measurement were performed in one third of the patients.
Conclusions: Present data from a large cohort of patients from the EUPSA-EAR show
both inter-institutional and intra-institutional variability in diagnostic workup of patients
with EA/TEF. Efforts should be made to develop guidelines on the diagnostic workup for
EA/TEF patients.
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INTRODUCTION
In 1974, Myers described esophageal atresia (EA) with/without tracheoesophageal fistula (TEF)
as “the epitome of modern surgery” (1) representing the compendium of all distinct features
of pediatric surgery. With such a binding definition, it may be expected that four decades later
the management of EA/TEF was well-defined and coded. However, recent studies exploring the
practice patterns in different centers have shown that controversies still exist in several aspects
of EA/TEF management (2–5). Most of the recent studies that collected multicenter data on the
management of patients with EA/TEF focused predominantly on operative approach and outcomes
(2–8). Interestingly, less attention has been dedicated to EA/TEF diagnostic work-up, although
this is crucial to drive the most appropriate treatment and to detect associated conditions that
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may have a substantial impact on patient outcomes. The aim
of this study was to analyze the current diagnostic policies in
EA/TEF patients enrolled in the first international multicenter
registry dedicated to EA/TEF and to describe inter-institutional
and intra-institutional variability in such policies.
METHODS
The European Paediatric Surgeons’ Association Esophageal
Atresia Registry (EUPSA-EAR; http://eupsa-registry.org/
registry) is a voluntary international collaboration born in 2014
to collect data on infants with EA/TEF managed at participating
Institutions. The EUPSA-EAR is based in the University of Graz
and has been approved for use by its Ethical Committee (number
27–259 ex 14/15). It is constituted of pediatric surgical units from
different European and non-European countries, whose Heads
are EUPSA members, and has two aims: to allow individual
centers to compare their results with the other participating
centers for benchmarking and to promote retrospective research
studies that would provide the basis for prospective studies.
Data on all infants with EA who were born at or transferred
to a participating center before any major esophageal surgery
were collected anonymously with an online form, cross-checked
for congruity, and entered into a central registry database.
Data collected prospectively contained information on prenatal
period and postnatal hospital care (including surgery when
applicable) until death or hospital discharge, and included data
on demographics, pre-operative, operative, and post-operative
management received, and outcomes. For the present study, we
considered the diagnostic work-up of all patients with EA/TEF
entered in the EUPSA-EAR between July 2014 and July 2017.
All recorded diagnostic procedures, including chest, abdominal
or skeletal X-rays, cardiac, abdominal or head ultrasounds,
preoperative bronchoscopy, esophagoscopy and gap assessment,
and chromosomal investigations were noted and differences in
their use within and between participating centers analyzed.
Individual research studies using EUPSA-EAR data do not
require further separate ethical approval, if only anonymized
data are used.
Statistical Analysis
Data were analyzed using IBM SPSS Package version 21
(IBM Corporation, Armonk, NY, USA; https://www.ibm.com/
products/spss-statistics). Chi-square test or Fisher’s exact test
were used to compare the prevalence of each diagnostic study in
the participating centers. Pearson’s test was used to analyze the
correlation between number of patients entered in the database
from each Institution and prevalence of each diagnostic study.
Probability values <0.05 were considered significant and two-
sided p-values are reported.
Results are reported as prevalence and median (range).
RESULTS
During the study period, 23 centers provided data on 374
neonates with EA/TEF (median number of patients per center 18,
range 1–54; Table 1). Twenty-eight (8%) patients died. Table 2
summarizes demographic data of patients’ population. Table 3
shows main findings. Chest X-ray and echocardiography were
almost uniformly performed in all patients, while esophagoscopy
TABLE 1 | Number of patients in each participating Institution.
























TABLE 2 | Demographic data of the study population.
Variable Median IQ Range
Gestational age (weeks) 38 35–39
Birth weight (grams) 2,670 2,054–3,150
Age at surgery (days) 2 2–3













Associated anomalies are not expressed as % as one patient may have more than one,
even in the same group (e.g., two or more cardiac anomalies in one single patient).
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TABLE 3 | Prevalence of different diagnostic investigations in the participating
Institutions.
Study Patients (%) Median % IQ Range % p
Chest X-ray 372 (99%) 100 (100–100) ns
Echocardiography 365 (98%) 100 (100–100) ns
Abdominal US 353 (94%) 100 (90–100) 0.0001
Abdominal X-ray 338 (90%) 100 (90–100) 0.0001
Head US 257 (69%) 100 (73–100) 0.0001
Skeletal X-ray 225 (60%) 63 (25–88) 0.0001
Bronchoscopy 137 (37%) 10 (0–60) 0.0001
Gap measurement 112 (30%) 0 (0–27) 0.0001
Gap VB 80 (71%) 20 (10–72) 0.0001
Chromosomal investigation 112 (30%) 22 (10–46) 0.0001
Esophagoscopy 28 (8%) 0 (0–0) 0.0001
was reported in only 8% of patients, being the less performed
diagnostic procedure. Bronchoscopy was performed in 137
(37%) patients. In particular, only 14% of the patients without
a distal TEF had a bronchoscopy. The gap was measured
pre-operatively in 112 (30%) patients. The methods for gap
measurement included (more than one possible) X-ray (105
patients), bronchoscopy (47 patients), and bronchoscopy and a
rigid instrument (endoscope/hegar dilator; 19 patients). Except
for chest x-ray and echocardiogram, all the other diagnostic
procedures were performed with some variability among the
participating centers (Figures 1, 2). No correlation was found
between the number of patients entered in the database by
the Institutions and the prevalence of each diagnostic study
included (Table 4). Fifteen patients entered in the Registry
had the most rare forms of EA (6 type D, 5 type B, 4 type
E according to Gross classification (9)). The sub-analysis of
these patients shows that also these rarest forms were studied
in variable way. All had cardiac ultrasound, all but one had
an abdominal ultrasound, abdominal X-rays were performed
in 12 patients, head ultrasound in 11, skeletal x-rays in 9,
only 4 had a bronchoscopy reported, 2 had an esophagoscopy,
the gap was measured in 2 and chromosomal study was
performed in 3.
DISCUSSION
In an analysis of over 370 neonates with EA/TEF prospectively
enrolled from several pediatric surgical units participating in
the EUPSA-EAR, we found a significant inter-institutional and
intra-institutional heterogeneity in patient diagnostic work-up.
Previous multicenter studies on EA/TEF management have
focused only marginally on the diagnostic work-up and have not
described the differences in approaches among the participating
centers (2–8). Significant differences in procedures among
centers may lead to difficulties in benchmarking centers and
comparing results. In the present study, specifically dedicated
to the diagnostic work-up of patients with EA/TEF, we found a
significant variability of the diagnostic approaches between the
participating centers. The variability was not correlated to the
number of patients registered by the different Institutions. Also,
the rarest forms of EA (type B, D, and E according to Gross
classification (9)), did not seem to have a more homogeneous
diagnostic work-up as compared to the more frequent forms.
Only chest X-rays and echocardiogram were performed in
almost every patient in all participating center. All the other
examinations were performed with a variable prevalence among
the participating centers (Table 3, Figures 1, 2). Previous surveys
found that the diagnostic approach to patients with EA/TEF
was not uniform among the surveyed surgeons. In a survey of
pediatric surgeons attending the joint BAPS-EUPSA meeting in
Rome in 2012, Zani et al. (5) report that 81% of respondents
would request a preoperative echocardiogram (while only 56%
would approach the EA/TEF from the left side should a right
aortic arch be detected) and 43% would perform a pre-operative
bronchoscopy. In the same survey, the gap was reported to
be measured intraoperatively by 60% of the respondents and
routine esophagoscopy to be performed by less than 20% of
respondents. Other diagnostic procedures included in our study
were not surveyed. Our findings confirm the ones from Zani
et al., but at the Institutional level. Reusens et al. (4), reviewing
the policies of pediatric surgical units in Belgium found that
preoperative bronchoscopy was performed in 36 and 46% of the
Units, depending on the presence or absence of a TEF. In present
cohort of patients, only 14% of patients without a TEF had a
bronchoscopy, that is much lower than what reported by Reusens
et al. Conversely, the prevalence of bronchoscopy in patients with
a TEF in the two studies was similar (38 and 36%). Intraoperative
gap assessment was reported by 43% of the units. Routine
esophagoscopy was performed in 21% of the units in case of EA
with TEF and 31% of the units in case of EA without TEF. These
surveys were not specifically designed to detect variability in
diagnostic approaches. Therefore, it is not possible to infer from
these data on the variability among different Institutions. Lal
et al. (2), reported on the perioperative management of EA/TEF
patients treated by the centers participating in the Midwest
Pediatric Surgery Consortium between 2009 and 2014. They
found wide variations in the use of several identified practices,
including some diagnostic examinations such as bronchoscopy,
which was performed in 64% of the patients, with a range
from 0 to 100% among the participating hospitals. From these
data and our findings, it is clear that wide variability in
diagnostic practices exists between different Institutions. This
inter-Institution variability may depend on the different case
mixes among the Institutions or may be secondary to different
protocols used. Whatever the reason, this variability may lead to
difficulties in the comparison of different Institutions and series
in terms of patient populations, practices and results.
Our study and the one by Lal et al. (2), also suggest a huge
intra-Institutional variability in the diagnostic work-up, that
does not seem to be associated with the number of patients
treated by the Institutions. In a single institution, most of the
identified examinations are not performed in all patients, but
only in a minority of them. These data suggest the lack of
strictly defined protocols guiding the diagnostic examinations
of EA/TEF patients, although such protocols are considered
crucial in the different phases of management, from surgical
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FIGURE 1 | Prevalence of abdominal ultrasound, head ultrasound, abdominal x-rays, and skeletal x-rays in each Institution participating in the EUPSA-EAR.
planning to long-term follow-up (10–12). This is particularly
true in some categories of patients with EA/TEF, including
extremely low birth weight infants, patients with a long gap,
with severe associated anomalies, or with a previously failed
anastomosis, that may represent difficult clinical challenges for
the surgeon. Therefore, a well-defined investigative strategy may
help to drive and prioritize surgical management (11, 12) and
follow-up program. However, there are a paucity of guidelines
for the management EA/TEF. The difficulty in developing sound
evidence-based guidelines may be due, at least in part, to the
rarity of EA/TEF. To understand the magnitude of the problem,
if one considers that EA/TEF incidence is roughly 1 in 4,000 live
births (13, 14), based on 2018 birth rates (15) ∼1,100 neonates
with EA would be expected in 28-country Europe. Furthermore,
considering that there are around 450 European pediatric surgery
units (16), an average of less than 3 patients would be seen
in each center every year. It is clear that no single institution
will have a sufficient number of children to design powerful
enough studies to provide accurate and meaningful evidence.
The logical step would be to design national and international
registries that may be instrumental in centralizing and collecting
data to give an overall picture of the disease, which could be
the basis for guidelines formation and subsequent prospective
studies and randomized trials, and provide quality indicators
that may be used to determine hospitals’ performance and best
practice variations. The importance of pediatric collaborative
networks for the progress in clinical care of patients with rare
disorders has been already pointed out (17–20). Accordingly,
the European Union is currently making an effort to develop
reference networks (ERN) of expert institutions for the treatment
of rare disorders, amongwhomERNICAwill focus specifically on
congenital gastro-intestinal disorders, including EA/TEF1. The
INoEA (International Network on Esophageal Atresia) is another
international collaboration dedicated to improving research and
care for EA patients, which has the development of a collaborative
database as one of its goals (18). The development of these
collaborations is currently underway. At present, few registries
are specifically dedicated to, and gather data on, EA/TEF patients:
the French National Esophageal Atresia Register (21), the
Turkish Esophageal Atresia Registry (22), and the EUPSA-EAR,
which is the only one at an international level. Whilst waiting
for the development of ERNICA and INoEA registries, the data
from the existing registries may prove helpful in advancing
EA/TEF patient care. In addition, these registries should continue
recording data, also to allow comparisons with new developing
registries data in the future.
This study has some limitations. Firstly, it is possible that
not all patients treated by each Institution were entered in the
Registry, as the Registry has a voluntary basis. This may lead to
1Available online at: https://ec.europa.eu/health/sites/health/files/ern/docs/
ernica_factsheet_en.pdf
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FIGURE 2 | Prevalence of pre-operative bronchoscopy, esophagoscopy, pre-operative gap assessment, and chromosomal investigations in each Institution
participating in the EUPSA-EAR.
TABLE 4 | Correlation between number of patients entered in the Registry and
prevalence of the diagnostic investigations in the participating Institutions
(Institutions with <3 patients entered in the Registry were excluded from this
analysis).
Diagnostic study Pearson r p
Abdominal ultrasound −0.07 0.77
Head ultrasound −0.37 0.10
Abdominal X-rays −0.26 0.25
Skeletal X-rays −0.12 0.60
Bronchoscopy 0.13 0.56
Oesophagoscopy 0.36 0.11
Gap measurement 0.10 0.67
Chromosomal test 0.03 0.89
biased analysis, as some patients may bemissed from the analysis.
However, it is plausible that the inclusion of more patients would
increase rather than reduce the variability in diagnostic work-
up. Second, the list of potential diagnostic procedures is not
exhaustive. However, the analysis of the diagnostic procedures
included in the study gives an idea of the extreme variability
that exists between different centers in the diagnostic work-up of
EA/TEF patients. Finally, the data collection was not purposely
designed to detect differences in EA/TEF diagnostic work-up.
As a result, some data may be missing or not declared, and this
potential bias may lead to an overestimation of the differences
between centers.
It goes beyond the scope of this study to discuss the
correct diagnostic work-up for patients with EA/TEF, although
a thorough preoperative work-up may change significantly
the management of a patients with EA/TEF. For example, a
preoperative tracheobronchoscopy may allow to change the
diagnosis from Gross type A EA (without TEF) to type B EA
(with a proximal TEF), that modifies significantly the treatment
and avoids leaving behind an unknown proximal TEF (23).
In conclusion, this first study from the first international
registry on EA/TEF on a relevant number of patients shows
inter-institutional and intra-institutional variability in the
diagnostic work-up of patients with EA/TEF. Efforts should
be made to develop shared guidelines on diagnostic workup
for EA/TEF patients. The use of currently available registries
may help in gathering data and promote the development of
such guidelines.
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